B.1.1 CTC of MOA & AOA amended upto 28 January, 2023
B.3_Fresh COI dated 11.08.2021
B.4_BR_Authorising Offer_17.09.2021
B.5_Shareholder Resolution_Authorising Offer_21.09.2021
B.6_BR Approving DRHP_29.09.2021
B.7_BR Approving Addendum to DRHP
B.8_BR and Shareholders Approval for Modification in OFS
B.9_BR_RHP Approval_22.10.2022
B.10_CTC- Prospectus Approval-November 9 2022
B.11_Consent Letter of Investor Selling Shareholder_11 10 2021
B.12 Share Purchase Agreement_13052017
B.13_Scheme of amalgamation and merger of NTAHS with Co
B.16_RJ Corp_ Investment Agreeement_Suppl Agreement and Undertaking
B.17_Agreement dated 13 05 2017_ Dr NT and SS
B.19_Agreement for CCPS Conversion_04.01.2022
B.20_Trademark License Agreement Amendment Agreements and Waiver Letters
B.21_Resolutions for appoinment of Dr NT as CMD
B.22_Resolutions for appoinmnet of Dr NT as Chaiman-Heart Institute and CCS
B.23_ BR dated July 25 2022 _Re appoinment of Dr NT as CMD
B.25_CA Examniation Report_02 09 22
B.26_Special tax Benefit Report_14 10 2022 (1)
B.27_Assessment of of the healthcare delivery market in India _26 09 2022
B.28_Consent for Assessment of Health Delivery Market_26 09 2022_CRSIL
B.29_Engagement Letter of CRISIl_15 09 22
B.31_Consent of CA to Include their name
B.32_Consent of RM Marwah CA to Include their name
B.33_Triparty Agreement btw Co CDSl Registrar_09 09 2021
B.34_Triparty Agreement btw Co NSDl Registrar_09 04 2021
B.35_DD Certificate_29 09 2021
We love to hear about our doctors, facilities
and your treatment at Medanta.
The User agrees and acknowledges that the User has read, understood and accepts the terms and conditions contained in the brochure provided with the Device (“Device”) with respect to its usage, operations, return / replacement and warranty policy.
The User hereby agrees and acknowledges that the Device (hardware and software) used in the provision
of services by Medanta is being provided on “as is” and “as available” basis through Alivecor India Private
Limited. Neither does Medanta endorse or promote the Device in any manner nor will Medanta be liable
for any claims, representations or warranties, whether express or implied as to the safety, reliability,
durability and performance of the device.
The services once availed cannot be cancelled except in cases where the User requests to cancel the
service on the day of purchase in which case, full amount of service fees shall be refunded to the User
provided that the Device has not been unboxed.
Before the expiry of service duration, the User can extend the services by availing various program
options. For the said purposes, the User can call our helpline number +91 124 4141414 or visit
www.medanta.org. The extended program availed by the User shall be activated automatically on expiry of existing program of services.
In cases where the User has opted for availing the Services through rented Device, a refundable deposit amount of ₹ 5,000 (“Deposit Amount”) shall be applicable and paid by the User. The refund of Deposit Amount shall be subject to return of the Device in working and undamaged condition. Refund of Deposit Amount shall be made through the same mode of payment as that of purchase in cases where the User personally visits the Medanta for returning the Device. If the User opts to return the Device through post, Deposit Amount shall be refunded electronically thorough NEFT or Bank transfer by Medanta within seven (7) working days of receipt of the Device and receipt of scanned image/copy of the ‘Cancelled Cheque’ of the User’s bank account.
Upon expiry of the services (either in terms of number of ECG or duration of the program) availed by the
User, the Device has to be returned within ten (10) days failing which the Deposit Amount shall be
forfeited.
Please note that the ECG pack or Refundable Device deposit are non-transferable from one patient to
another.